Fibrogen appoints deyaa adib, m.d. as chief medical officer

San francisco, march 11, 2024 (globe newswire) -- fibrogen, inc. (nasdaq: fgen) today announced the appointment of deyaa adib, m.d., an executive leader with almost three decades of oncology development experience, as senior vice president & chief medical officer to oversee all global clinical development activities. the appointment is effective march 11, 2024.

FGEN Ratings Summary

FGEN Quant Ranking